1. Home
  2. PKX vs CRL Comparison

PKX vs CRL Comparison

Compare PKX & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo POSCO Holdings Inc.

PKX

POSCO Holdings Inc.

HOLD

Current Price

$51.53

Market Cap

15.8B

Sector

Industrials

ML Signal

HOLD

Logo Charles River Laboratories International Inc.

CRL

Charles River Laboratories International Inc.

HOLD

Current Price

$344.75

Market Cap

13.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PKX
CRL
Founded
1968
1947
Country
South Korea
United States
Employees
42873
N/A
Industry
Steel/Iron Ore
Biotechnology: Commercial Physical & Biological Resarch
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.8B
13.1B
IPO Year
1998
1999

Fundamental Metrics

Financial Performance
Metric
PKX
CRL
Price
$51.53
$344.75
Analyst Decision
Buy
Analyst Count
0
18
Target Price
N/A
★ $315.53
AVG Volume (30 Days)
158.0K
★ 1.0M
Earning Date
11-02-2026
11-04-2026
Dividend Yield
★ 2.29%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $1,857,601,000.00
Revenue This Year
$7.27
N/A
Revenue Next Year
$3.74
$2.55
P/E Ratio
$42.95
★ N/A
Revenue Growth
N/A
★ 10.48
52 Week Low
$48.50
$146.20
52 Week High
$92.40
$351.21

Technical Indicators

Market Signals
Indicator
PKX
CRL
Relative Strength Index (RSI) 34.15 72.88
Support Level $49.41 $151.03
Resistance Level $59.47 N/A
Average True Range (ATR) 1.07 14.50
MACD -0.41 4.19
Stochastic Oscillator 2.99 89.89

Price Performance

Historical Comparison
PKX
CRL

About PKX POSCO Holdings Inc.

POSCO Holdings Inc is a holding company operating through its subsidiaries. Its business is divided into segments, with the Steel segment generating the majority of revenue from the manufacture and sale of steel products. The Infrastructure segment includes trading, construction, and logistics and system integration activities. The Rechargeable Battery Materials segment focuses on EV battery materials such as lithium, nickel, and cathode and anode materials. The Others segment includes the controlling company and investment business. Geographically, the Group generates majority of its revenue from Asia (excluding China and Japan).

About CRL Charles River Laboratories International Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provide in vitro (nonanimal) testing products, biologics testing services, and avian vaccine services.

Share on Social Networks: